ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,138, issued on Oct. 7, was assigned to Philikos B.V. (Nijmegan, Netherlands).

"Immunotoxins, formulations thereof and their use in medicine" was invented by Henricus Gerardus Van Hooren (Nijmegen, Netherlands), Maarten Jaap Frijlink (Nijmegen, Netherlands) and Ypke Vincentius Johannes Maria Van Oosterhout (Nijmegen, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a composition comprising a first antibody molecule that specifically recognizes CD3 and a second antibody molecule that specifically recognizes CD7, for use in a method of treatment, or preventative treatment of viral infection or viral reactivation ...